ONWARD MEDICAL (ONWD.BR) Stock Income Statement
EBR:ONWD - Euronext Brussels - NL0015000HT4 - Common Stock - Currency: EUR
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 229.00K | 68.00K | 104.00K | 0.00 | 0.00 | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 22.00K | N/A | N/A | N/A | N/A | |||
| Gross Profit | 207.00K | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 35.07M | 35.53M | 32.13M | 28.53M | 15.51M | |||
| Research and Development | 17.20M | 18.75M | 18.89M | 15.39M | 9.51M | |||
| Selling, General, and Administrative Expenses | 18.48M | 16.52M | 14.56M | 13.18M | 5.63M | |||
| Operating Income | -34.86M | -35.46M | -32.03M | -28.53M | -15.51M | |||
| Interest Income/Expense | -814.00K | -594.00K | -1.48M | -5.70M | -4.47M | |||
| Other Income/Expense | -89.00K | -17.00K | -33.00K | -16.00K | -12.00K | |||
| Income Before Taxes | -35.77M | -36.07M | -33.54M | -34.24M | -19.99M | |||
| Income Tax | -40.00K | 107.00K | -766.00K | 69.00K | 20.00K | |||
| Net Income | -35.73M | -36.18M | -32.77M | -34.31M | -20.01M | |||
| EBITDA | -33.96M | -34.74M | -31.29M | -28.20M | -15.24M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.80 | -1.20 | -1.09 | -3.62 | -0.67 | |||
| Statistics | ||||||||
| Gross Profit Margin | 90.39% | N/A | N/A | N/A | N/A | |||
| Profit Margin | -15600.44% | -53207.35% | -31511.54% | N/A | N/A | |||
| Operating Profit Margin | -15223.58% | -52151.47% | -30796.15% | N/A | N/A | |||
All data in EUR